Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 26
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Complications of a severe autoimmune hemolytic anemia crisis: transfusional iron overload and gangrenous cholecystitis | Menchetti I, Lin Y, Cserti-Gazdewich C, Goldstein J, Law C, Lazarus A, Callum JL | 2018 | Transfusion | View Complications of a severe autoimmune hemolytic anemia crisis: transfusional iron overload and gangrenous cholecystitis | Researchers | Clinical research |
Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia | Spaner DE, Venema R, Huang J, Norris P, Lazarus A, Wang G, Shi Y | 2018 | EBioMedicine | View Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia | Health care providers | Clinical research |
Platelet immunobiology: platelets as prey and predator | Kapur R, Semple JW | 2018 | ISBT Sci Ser | View Platelet immunobiology: platelets as prey and predator | Researchers | Basic research |
Risk of acute kidney injury in patients randomized to a restrictive versus liberal approach to red blood cell transfusion in cardiac surgery: a substudy protocol of the transfusion requirements in cardiac surgery III noninferiority trial | Garg AX, Shehata N, McGuinness S, Whitlock R, Fergusson D, Wald R, Parikh C, Bagshaw SM, Khanykin B, Gregory A, Syed S, Hare GMT, Cuerden MS, Thorpe KE, Hall J, Verma S, Roshanov PS, Sontrop JM, Mazer CD | 2018 | Can J Kidney Health Dis | View Risk of acute kidney injury in patients randomized to a restrictive versus liberal approach to red blood cell transfusion in cardiac surgery: a substudy protocol of the transfusion requirements in cardiac surgery III noninferiority trial | Researchers | Clinical research |
Adverse reactions reporting | Chargé S, Young D | 2018 | Blood.ca website | View Adverse reactions reporting | Health care providers | Other |
Initial flow cytometric evaluation of the Clearllab lymphoid screen | Hedley BD, Cheng G, Luider J, Kern W, Lozanski G, Chin-Yee I, Lowes LE, Keeney M, Careaga D, Magari R, Tejidor L | 2018 | Cytometry B Clin Cytom | View Initial flow cytometric evaluation of the Clearllab lymphoid screen | Researchers | Basic research |
Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review | Kjaer M, Bertrand G, Bakchoul T, Massey E, Baker JM, Lieberman L, Tanael S, Greinacher A, Murphy MF, Arnold DM, Baidya S, Bussel J, Hume H, Kaplan C, Oepkes D, Ryan G, Savoia H, Shehata N, Kjeldsen-Kragh J, International Collaboration for Transfusion Medicine Guidelines | 2018 | Vox Sang | View Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review | Researchers | Clinical research |
Clinical Outcomes and Red Blood Cell Storage | Ning S, Heddle NM | 2018 | Hematologic Challenges in the Critically Ill | View Clinical Outcomes and Red Blood Cell Storage | Other | Other |
Les concentrés de facteurs de coagulation | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Les concentrés de facteurs de coagulation | Health care providers | Other |
Hemostatic efficacy of pathogen-inactivated versus untreated platelets: a randomized controlled trial | van der Meer PF, Ypma PF, van Geloven N, van Hilten JA, van Wordragen-Vlaswinkel RJ, Eissen O, Zwaginga JJ, Trus M, Beckers EAM, te Boekhorst P, Tinmouth A, Lin Y, Hsia C, Lee D, Norris PJ, Goodrich RP, Brand A, Hervig T, Heddle NM, van der Bom JG, Kerkhoffs J-LH | 2018 | Blood | View Hemostatic efficacy of pathogen-inactivated versus untreated platelets: a randomized controlled trial | Researchers | Clinical research |
Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | de Wit K | 2018 | CanadiEM website | View Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | Health care providers | Benchmarking and standard setting |
Routine screening method for microparticles in platelet transfusions | Millar D, Murphy L, Labrie A, Maurer-Spurej E | 2018 | J Vis Exp | View Routine screening method for microparticles in platelet transfusions | Health care providers | New or improved product or process |
Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score | Balitsky AK, Kelton JG, Arnold DM | 2018 | Blood | View Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score | Researchers | New or improved product or process |
Focusing in on use of pharmacokinetic profiles in routine hemophilia care | Croteau SE, Callaghan MU, Davis J, Dunn AL, Guerrera M, Khan O, Neufeld EJ, Raffini LJ, Recht M, Wang M, Iorio A | 2018 | Res Pract Thromb Haemost | View Focusing in on use of pharmacokinetic profiles in routine hemophilia care | Health care providers | Clinical research |
Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project | Iorio A, Skinner MW, Clearfield E, Messner D, Pierce GF, Witkop M, Tunis S | 2018 | Haemophilia | View Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project | Health care providers | Clinical research |
The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2 | Lemay A-S, Tong TN, Branch DR, Huang M, Sumner C, Oldfield L, Hawes J, Cserti-Gazdewich CM, Lau W | 2018 | Transfusion | View The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2 | Researchers | Clinical research |
Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial | Pai M, Adhikari NKJ, Ostermann M, Heels-Ansdell D, Douketis JD, Skrobik Y, Qushmaq I, Meade M, Guyatt G, Geerts W, Walsh MW, Crowther MA, Friedrich JO, Burry L, Bellomo R, Brandao da Silva N, Costa Filho R, Cox MJ, Alves Silva S, Cook DJ, on behalf of the PROTECT Investigators | 2018 | PLoS One | View Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial | Researchers | Clinical research |
Ultraviolet-based pathogen inactivation systems: untangling the molecular targets activated in platelets | Schubert P, Johnson L, Marks DC, Devine DV | 2018 | Front Med | View Ultraviolet-based pathogen inactivation systems: untangling the molecular targets activated in platelets | Researchers | Basic research |
Intravenous immune globulin to prevent heparin-induced thrombocytopenia | Warkentin TE, Climans TH, Morin P-A | 2018 | N Engl J Med | View Intravenous immune globulin to prevent heparin-induced thrombocytopenia | Health care providers | Other |
Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers | Visram A, Bredeson C, Allan D, Sabloff M, Huebsch L, Tay J, Kekre N, McDiarmid S, Mallick R, Tinmouth A, Martin L, Hamelin L, Maze D | 2018 | Blood Cancer J | View Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers | Health care providers | Clinical research |
Assignment of cytomegalovirus infection status in infants awaiting solid organ transplant: Viral detection methods as adjuncts to serology | Burton CE, Dragan T, Mabilangan CA, O'Brien SF, Fearon M, Scalia V, Preiksaitis JK | 2018 | Pediatr Transplant | View Assignment of cytomegalovirus infection status in infants awaiting solid organ transplant: Viral detection methods as adjuncts to serology | Health care providers | Clinical research |
Improving Time to Antibiotics for Pediatric Oncology Patients With Fever and Suspected Neutropenia by Applying Lean Principles | Geerlinks AV, Digout C, Bernstein M, Chan A, MacPhee S, Pambrun C, Gallant G, Wyatt L, Fernandez CV, Price VE | 2018 | Pediatric Emergency Care | View Improving Time to Antibiotics for Pediatric Oncology Patients With Fever and Suspected Neutropenia by Applying Lean Principles | Researchers | New or improved product or process |
More than one way to enhance bacterial detection in platelet components | Kamel H, Goldman M | 2018 | Transfusion | View More than one way to enhance bacterial detection in platelet components | Other | New or improved product or process |
rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and Fc?Rs | Spirig R, Campbell IK, Koernig S, Chen C-G, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Kaesermann F, Zuercher AW | 2018 | J Immunol | View rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and Fc?Rs | Researchers | Basic research |
Acquired factor XIII deficiency: A review | Yan MTS, Rydz N, Goodyear D, Sholzberg M | 2018 | Transfus Apher Sci | View Acquired factor XIII deficiency: A review | Researchers | Other |
Donor deferral policies for men who have sex with men: past, present and future | Goldman M, Shih AW, O'Brien SF, Devine D | 2018 | Vox Sang | View Donor deferral policies for men who have sex with men: past, present and future | Health care providers | MSM research |
Pathogen reduction technologies: The pros and cons for platelet transfusion | Magron A, Laugier J, Provost P, Boilard E | 2018 | Platelets | View Pathogen reduction technologies: The pros and cons for platelet transfusion | Blood operators | Basic research |
ResearchUnit: A different way to look at red blood cell quality | Acker J | 2018 | Blood.ca website | View ResearchUnit: A different way to look at red blood cell quality | Researchers | Clinical research |
Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections | Charlton CL, Babady E, Ginocchio CC, Hatchette TF, Jerris RC, Li Y, Loeffelholz M, McCarter YS, Miller MB, Novak-Weekley S, Schuetz AN, Tang Y-W, Widen R, Drews SJ | 2018 | Clin Microbiol Rev | View Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections | Health care providers | Clinical research |
Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia | Huynh A, Arnold DM, Kelton JG, Smith JW, Horsewood P, Clare R, Guarné A, Nazy I | 2018 | J Thromb Haemost | View Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia | Researchers | Basic research |
IVIg and LPS Co-stimulation Induces IL-10 Production by Human Monocytes, Which Is Compromised by an FcgRIIA Disease-Associated Gene Variant | Kozicky LK, Menzies SC, Zhao ZY, Vira T, Harnden K, Safari K, Del Bel KL, Turvey SE, Sly LM | 2018 | Front Immunol | View IVIg and LPS Co-stimulation Induces IL-10 Production by Human Monocytes, Which Is Compromised by an FcgRIIA Disease-Associated Gene Variant | Researchers | Basic research |
What's in a name? Patient registration errors and their threat to transfusion safety | Ning S, Yan MTS, Downie H, Callum J | 2018 | Transfusion | View What's in a name? Patient registration errors and their threat to transfusion safety | Researchers | New or improved product or process |
Hemostatic Disorders and Hereditary Angioedema | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Clinical Guide to Transfusion | View Hemostatic Disorders and Hereditary Angioedema | Health care providers | Other |
Raman spectroscopy of stored red blood cell concentrate within sealed transfusion blood bags | Vardaki MZ, Atkins CG, Schulze HG, Devine DV, Serrano K, Blades MW, Turner RFB | 2018 | Analyst | View Raman spectroscopy of stored red blood cell concentrate within sealed transfusion blood bags | Researchers | New or improved product or process |
Blood and clots series: My patient has a pulmonary embolism. Should I screen them for cancer? | Tseng E | 2018 | CanadiEM website | View Blood and clots series: My patient has a pulmonary embolism. Should I screen them for cancer? | Health care providers | Benchmarking and standard setting |
Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population | Marchesini E, Oliovecchio E, Coppola A, Santagostino E, Radossi P, Castaman G, Valdre L, Santoro C, Tagliaferri A, Ettorre C, Zanon E, Barillari G, Cantori I, Caimi TM, Sottilotta G, Iorio A, Mannucci PM | 2018 | Haemophilia | View Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population | Health care providers | Clinical research |
Le déficit en IgA | Goldman M | 2018 | Blood.ca website | View Le déficit en IgA | Health care providers | Benchmarking and standard setting |
Platelet-activating antibodies are detectable at the earliest onset of heparin-induced thrombocytopenia, with implications for the operating characteristics of the serotonin-release assay | Warkentin TE, Arnold DM, Kelton JG, Sheppard JI, Smith JW, Nazy I | 2018 | Chest | View Platelet-activating antibodies are detectable at the earliest onset of heparin-induced thrombocytopenia, with implications for the operating characteristics of the serotonin-release assay | Researchers | Clinical research |
Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016 | Vostal JG, Buehler PW, Gelderman MP, Alayash AI, Doctor A, Zimring JC, Glynn SA, Hess JR, Klein H, Acker JP, Spinella PC, D'Alessandro A, Palsson B, Raife TJ, Busch MP, McMahon TJ, Intaglietta M, Swartz HM, Dubick MA, Cardin S, Patel RP, Natanson C, Weisel JW, Muszynski JA, Norris PJ, Ness PM | 2018 | Transfusion | View Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016 | Researchers | New or improved product or process |
Modelling the Need for New Blood Donors Following a Change in Deferral Period | Blake J | 2018 | Industrial Engineering and Operations Management I | View Modelling the Need for New Blood Donors Following a Change in Deferral Period | Researchers | Clinical research |
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. | Cuker A AG, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N | 2018 | Blood Adv | View American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. | Health care providers | Benchmarking and standard setting |
Assessing opportunities and challenges for establishing a national program to distribute cord blood for research | Isasi R, Mastronardi C, Golder M, Allan D, Walker M, Halpenny M, Yang L, Elmoazzen H, Chargé S | 2018 | Transfusion | View Assessing opportunities and challenges for establishing a national program to distribute cord blood for research | Researchers | Other |
GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out | Lewis BJB, Leontyev D, Neschadim A, Blacquiere M, Branch DR | 2018 | Clin Exp Immunol | View GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out | Researchers | Basic research |
The importance of iron for whole blood donors: a Canadian perspective | Pambrun C, Goldman M | 2018 | Blood.ca website | View The importance of iron for whole blood donors: a Canadian perspective | Health care providers | Other |
ResearchUnit: Plasma: what's in the bag? | Sheffield W, Jenkins C | 2018 | Blood.ca website | View ResearchUnit: Plasma: what's in the bag? | Researchers | Basic research |
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo?controlled trials | Bussel J, Arnold DM, Grossbard E, Mayer J, Treliski J, Homenda W, Hellmann A, Windyga J, Sivcheva L, Khalafallah AA, Zaja F, Cooper N, Markovtsov V, Zayed H, Duliege AM | 2018 | Am J Hematol | View Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo?controlled trials | Health care providers | Clinical research |
Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brain | Mistry N, Mazer CD, Sled JG, Lazarus AH, Cahill LS, Solish M, Zhou Y-Q, Romanova N, Hare AGM, Doctor A, Fisher JA, Brunt KR, Simpson JA, Hare GMT | 2018 | Am J Physiol Regul Integr Comp Physiol | View Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brain | Researchers | Basic research |
Evaluation of a hydrogel-based diagnostic approach for the point-of-care based detection of Neisseria gonorrhoeae | Perera S, Taheri A, Khan N, Parti R, Stefura S, Skiba P, Acker J, Martin I, Kusalik A, Dillon J-A | 2018 | Antibiotics | View Evaluation of a hydrogel-based diagnostic approach for the point-of-care based detection of Neisseria gonorrhoeae | Researchers | New or improved product or process |
Enhancing the pro-inflammatory anti-cancer T cell response via biomanufactured, secretome-based, immunotherapeutics | Yang X, Kang N, Toyofuku WM, Scott MD | 2018 | Immunobiology | View Enhancing the pro-inflammatory anti-cancer T cell response via biomanufactured, secretome-based, immunotherapeutics | Researchers | Basic research |
A brief survey of clinicians' perceptions of parent preferences for involvement in obstetrical and perinatal management decisions in haemophilia | Lucier KJ, Movilla RV, Parvizian MK, Siddiqui R, Gabriele EH, Bourque M, MacIsaac J, Moorehead PC, Chan AK, Heddle NM, Lane SJ | 2018 | Haemophilia | View A brief survey of clinicians' perceptions of parent preferences for involvement in obstetrical and perinatal management decisions in haemophilia | Health care providers | Clinical research |